UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN C000000279
Receipt No. R000000356
Scientific Title Randomized phase III trial of surgery plus neoadjubant TS-1 and cisplatin compared with surgery alone for type 4 and large type 3 gastric cancer: Japan Clinical Oncology Group Study (JCOG 0501)
Date of disclosure of the study information 2005/11/08
Last modified on 2016/09/13 11:52:00

No. Disposal Last modified on Item of update
1 Insert 2005/11/08 19:20:28
2 Update 2006/11/25 16:16:04 Recruitment status
3 Update 2007/11/13 19:30:51 Recruitment status
Last follow-up date
4 Update 2007/12/14 14:38:37 Narrative objectives1
Narrative objectives1
5 Update 2007/12/14 14:49:28 Interventions/Control_1
Interventions/Control_1
Interventions/Control_2
Interventions/Control_2
Key inclusion criteria
6 Update 2007/12/14 14:51:21 Last name of lead principal investigator
7 Update 2007/12/14 14:52:38 Target sample size
8 Update 2009/01/23 11:24:11 Organization
Organization
Division name
Division name
Address
Address
Name of person sending information
Name of person sending information
Organization
Organization
Division name
Division name
TEL
9 Update 2009/05/08 11:52:34 Name of person sending information
Name of person sending information
10 Update 2009/11/13 17:17:23 Recruitment status
11 Update 2009/11/13 17:21:52 Institutions
12 Update 2011/05/09 11:52:41 Institutions
13 Update 2011/12/02 17:43:34 Post marketing survey by drug manufacture etc., specified by Japanese law.
14 Update 2012/05/24 16:40:15 Institutions
15 Update 2012/05/31 14:37:57 Institutions
16 Update 2012/06/20 11:55:22 Acronym
17 Update 2013/07/19 17:14:16 Recruitment status
18 Update 2015/02/02 17:33:26 TEL
Email
Division name
Division name
TEL
Institutions
19 Update 2015/02/02 17:34:11 Last follow-up date
20 Update 2015/02/03 12:03:58 Narrative objectives1
Key secondary outcomes
21 Update 2015/02/03 12:09:21 Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
Key exclusion criteria
22 Update 2015/05/11 17:43:41 Institutions
23 Update 2016/09/13 11:50:08 Anticipated trial start date
Last follow-up date
24 Update 2016/09/13 11:50:39 Last follow-up date
25 Update 2016/09/13 11:52:00 Name of primary sponsor
Organization
Category of Funding Organization


Contact us.